Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-07-17
1999-09-07
Lilling, Herbert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 514171, 514412, 514470, 514561, 514563, 514565, 514648, 514651, 514652, 514742, 514841, 514843, A61K 3104, A61K 3156, A61K 31195, A61K 31155
Patent
active
059487623
ABSTRACT:
Dysmenorrhea, disfunctional uterine bleeding, preterm labor and postpartum labor in female mammals are treated by inhibiting uterine contractility by administering thereto a nitric oxide synthase substrate, a nitric oxide donor or both, optionally in combination with one or more of a prostaglandin inhibitor, a prostacyclin-mimetic, a progestin, an oxytocin antagonist or a .beta.-agonist in an amount effective to ameliorate the symptoms thereof; and inadequate menses treated and induction of abortion or stimulation of labor in a pregnant female is achieved by uterine contractility stimulation by administering thereto a nitric oxide inhibitor, either alone or optionally in a combination of progesterone antagonist, an oxytocin or-oxytocin analogue antagonist or a prostaglandin.
REFERENCES:
patent: 5217997 (1993-06-01), Levere et al.
patent: 5508045 (1996-04-01), Harrison et al.
Yallampalli et al., Soc. Gynecol. Invest. Abst. P41 (1993).
Ramsey et al., Europ. J. of Clinical Investigation, 24:76-78 (1994).
Sladek et al., Endocrinology, 133(4):1899-1904 (1993).
Yallampalli et al., Am. J. Obstet. Gynecol., 169: 1316-1320 (1993).
Yallampalli et al., Am. J. Obstet. Gynecol., 169:1285-1291 (1993).
Yallampalli et al., Am. J. Obstet. Gynecol., 170:175-185 (1993).
Yallampalli et al., Endocrinology, 134(4):1971 (1994).
Greenspoon et al., Lancet, 338:124 (1991).
Izumi et al., Am. J. Obstet. Gynecol., 170:236-245 (1994).
Jennings et al., J. of Mat. Fetal Med., 2:170-175 (1993).
Lees et al., Lancet, 343:1325-1326 (1994).
Natuzzi et al., Biochem. & Biophys. Res. Comm., 194(1):1-8 (1993).
Papka et al., Neuroscience Letters, 147:224-228 (1992).
Bayhi et al., J. Clin. Anesth., 4:487-488 (1992).
Conrad, FASEB, 7:566-571 (1993).
Diamond, J. of Pharm. & Exp. Thera., 168(1):21-30 (1969).
Garfield et al., "Control of Myometrial Contractility and Labor, " Basic Mechanisms Controlling Term and Preterm Labor, Springer-Verlag Berlin, eds. Chwalisz et al. (1994).
Bukowski Radoslaw
Chwalisz Krzysztof
Garfield Robert E.
Yallampalli Chandra
Lilling Herbert J.
Schering Aktiengesellschaft
The University of Texas System
LandOfFree
Treatment of uterine contractility disorders with a nitric oxide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of uterine contractility disorders with a nitric oxide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of uterine contractility disorders with a nitric oxide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1804605